首页|期刊导航|Oncology Research|Evaluating the efficacy and safety of Anlotinib in conjunction with stereotactic radiosurgery for small cell lung cancer patients with brain metastases

Evaluating the efficacy and safety of Anlotinib in conjunction with stereotactic radiosurgery for small cell lung cancer patients with brain metastases

LIZHI WANG HUILIN SUN GUIZHI YU ZEJING QU YING JI YANPING CUI

Oncology Research2025，Vol.33Issue(4)：P.885-894,10.

Oncology Research2025，Vol.33Issue(4)：P.885-894,10.DOI:10.32604/or.2024.051586

Evaluating the efficacy and safety of Anlotinib in conjunction with stereotactic radiosurgery for small cell lung cancer patients with brain metastases

LIZHI WANG ¹HUILIN SUN ²GUIZHI YU ¹ZEJING QU ¹YING JI ¹YANPING CUI¹

作者信息

1. Department of Radiation Oncology,Chengde Central Hospital,Chengde,067000,China
2. Department of Hematology,Chengde Central Hospital,Chengde,067000,China
折叠

摘要

关键词

Small cell lung cancer(SCLC)/Brain metastasis/Anlotinib/Stereotactic radiotherapy/Intracranial progression-free survival

分类

医药卫生

引用本文复制引用

LIZHI WANG,HUILIN SUN,GUIZHI YU,ZEJING QU,YING JI,YANPING CUI..Evaluating the efficacy and safety of Anlotinib in conjunction with stereotactic radiosurgery for small cell lung cancer patients with brain metastases[J].Oncology Research,2025,33(4):P.885-894,10.

基金项目

supported by the Science and Technology Program of Chengde(Project Number:202301A016). （Project Number:202301A016）

Oncology Research

ISSN：0965-0407

访问量0

下载量0

段落导航